Metabolic syndrome X: An inflammatory condition?

Current Hypertension Reports

Volumn 6, Issue 1, 2004, Pages 66-73

  Das, Undurti N ^a  

^a Reflexis Systems Inc   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ADIPONECTIN; ANGIOTENSIN RECEPTOR; ANGIOTENSIN RECEPTOR ANTAGONIST; ANTIHYPERTENSIVE AGENT; BETA ADRENERGIC RECEPTOR; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; BIOCHEMICAL MARKER; C REACTIVE PROTEIN; DIPEPTIDYL CARBOXYPEPTIDASE; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; FIBRINOGEN; HIGH DENSITY LIPOPROTEIN CHOLESTEROL; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; INDUCIBLE NITRIC OXIDE SYNTHASE; INSULIN; INTERCELLULAR ADHESION MOLECULE 1; INTERLEUKIN 10; INTERLEUKIN 4; INTERLEUKIN 6; LIPID PEROXIDASE; MONOCYTE CHEMOTACTIC PROTEIN 1; OCTREOTIDE; TUMOR NECROSIS FACTOR ALPHA;

ADIPOSE TISSUE; ADRENERGIC RECEPTOR BLOCKING; ANTIHYPERTENSIVE ACTIVITY; ARTICLE; ATHEROSCLEROSIS; CARDIOVASCULAR RISK; CYTOKINE PRODUCTION; DIET RESTRICTION; DISEASE ASSOCIATION; DISEASE PREDISPOSITION; ENZYME INHIBITOR COMPLEX; ESSENTIAL HYPERTENSION; HIGH RISK POPULATION; HUMAN; HYPERINSULINEMIA; INSULIN RESISTANCE; ISCHEMIC HEART DISEASE; METABOLIC SYNDROME X; NON INSULIN DEPENDENT DIABETES MELLITUS; OBESITY; PATHOGENESIS; PREVALENCE; PROTEIN BLOOD LEVEL; WEIGHT REDUCTION;

EID: 5444246811     PISSN: 15226417     EISSN: None     Source Type: Journal    
DOI: 10.1007/s11906-004-0014-8     Document Type: Article

References (74)

1. Hansen BC, Jen K-L, Schwartz J: Changes in insulin responses and binding in adipocytes from monkeys with obesity progressing to diabetes. Int J Obes 1988, 12:433-443.
2. Bjorntorp P: Adipose tissue distribution and function. Int J Obes 1991, 15(Suppl 2):67-81.
3. Pederson O, Hjollund E, Lindskov HO: Insulin binding and action on fat cells from young healthy females and males. Am J Physiol 1982, 243:E158-E167.
4. Ramos EJB, Xu Y, Romanova I, et al.: Is obesity an inflammatory disease? Surgery 2003, 134:329-335.
5. Das UN: Sex differences in the number of adipose cells. XX vs XY, 2003, 1:132-133.
6. Masuzaki H, Paterson J, Shinyama H, et al.: A transgenic model of visceral obesity and the metabolic syndrome. Science 2001, 294:2166-2170.
7. Das UN: Metabolic syndrome X is common in South Asians, but why and how? Nutrition 2002, 18:774-776.
8. Das UN: Is metabolic syndrome X an inflammatory condition? Exp Biol Med 2002, 227:989-997.
9. Das UN: Is obesity an inflammatory condition? Nutrition 2001, 17:953-966.
10. Das UN: Obesity, metabolic syndrome X, and inflammation. Nutrition 2002, 18:430-432.
11. Albert MA, Glynn RJ, Ridker PM: Plasma concentration of C-reactive protein and the calculated Framingham coronary heart disease risk score. Circulation 2003, 108:161-165.
12. van der Meer IM, de Maat MPM, Hak AE, et al.: C-reactive protein predicts progression of atherosclerosis measured as various sites in the arterial tree. The Rotterdam Study. Stroke 2002, 33:2750-2755.
13. Luc G, Bard J-M, Juhan-Vague I, et al.: C-reactive protein, interleukins-6, and fibrinogen as predictors of coronary heart disease. The PRIME study. Arterioscler Thromb Vasc Biol 2003, 23:1255-1261.
14. Ridker PM, Cushman M, Stampfer MJ, et al.: Inflammation, aspirin, and the risk of cardiovascular disease in apparently healthy men. N Engl J Med 1997, 336:973-979.
15. Engstrom G, Hedblad B, Stavenow L, et al.: Inflammation-sensitive plasma proteins are associated with future weight gain. Diabetes 2003, 52:2097-2101.
16. Mosca L: C-reactive protein-to screen or not to screen. N Engl J Med 2002, 347:1615-1617.
17. Castell JV, Gomez-Lechon MJ, David M, et al.: Recombinant human interleukins-6 (IL-6/BSF-2/HSF) regulates the synthesis of acute phase proteins in human hepatocytes. FEBS Lett 1988, 232:347-350.
18. Barzilay JI, Abraham L, Heckbert SR, et al.: The relation of markers of inflammation to the development of glucose disorders in the elderly. Diabetes 2001, 50:2384-2389.
19. Kirwan JP, Krishnan RK, Weaver JA, et al.: Human aging is associated with altered TNF-alpha production during hyperglycemia and hyperinsulinemia. Am J Physiol 2001, 281: E1137-E1143.
20. Lin Y, Rajala MW, Berger JP, et al.: Hyperglycemia-induced production of acute phase reactants in adipose tissue. J Biol Chem 2001, 276:42077-42083.
21. Hotamisligil GS: The role of TNF-alpha and TNF receptors in obesity and insulin resistance. J Intern Med 1999, 245:621-625.
22. Esposito K, Nappo F, Marfella R, et al.: Inflammatory cytokine concentrations are acutely increased by hyperglycemia in humans: role of oxidative stress. Circulation 2002, 106:2067-2072.
23. Liu S, Manson JE, Boring JE, et al.: Relation between a diet with a high glycemic load and plasma concentrations of high-sensitivity C-reactive protein in middle-aged women. Am J Clin Nutr 2002, 75:492-498.
24. Mohanty P, Hamouda W, Garg R, et al.: Glucose challenge stimulates reactive oxygen species (ROS) generation by leucocytes. J Clin Endocrinol Metab 2000, 85: 2970-2973.
25. Mohanty P, Ghanim H, Hamouda W, et al.: Both lipid and protein intakes stimulate increased generation of reactive oxygen species by polymorphonuclear leukocytes and mononuclear cells. Am J Clin Nutr 2002, 75:767-772.
26. Fan J, Frey RS, Rahman A, Malik AB: Role of neutrophil NADPH oxidase in the mechanism of tumor necrosis factor alpha-induced NF-kB activation and intercellular adhesion molecule-1 expression in endothelial cells. J Biol Chem 2002, 277:3404-3411.
27. Mohan IK, Das UN: Oxidant stress, anti-oxidants and nitric oxide in non-insulin dependent diabetes mellitus. Med Sci Res 1997, 25:55-57.
28. Das UN: Oxy radicals and their clinical implications. Curr Sci 1993, 65:964-968.
29. Kumar KV, Das UN: Lipid peroxides and essential fatty acids in patients with coronary heart disease. J Nutr Med 1994, 4:33-37.
30. Das UN, Kumar KV, Mohan IK: Lipid peroxides and essential fatty acids in patients with diabetes mellitus and diabetic nephropathy. J Nutr Med 1994, 4:149-155.
31. Kumar KV, Das UN: Are free radicals involved in the pathobiology of human essential hypertension? Free Rad Res Commun 1993, 19:59-66.
32. Das UN: Folic acid says NO to vascular diseases. Nutrition 2003, 19:686-692.
33. Ridker PM, Buring JE, Cook NR, Rifai N: C-reactive protein, the metabolic syndrome, and risk of incident cardiovascular events. Circulation 2003, 107:391-397.
34. Kern PA, Di Gregorio GB, Lu T, et al.: Adiponectin expression from human adipose tissue: relation to obesity, insulin resistance, and tumor necrosis factor-a expression. Diabetes 2003, 52:1779-1785.
35. Bruun JM, Lihn AS, Verdich C, et al.: Regulation of adiponectin by adipose tissue-derived cytokines: in vivo and in vitro investigations in humans. Am J Physiol Endocrinol Metab 2003, 285:E527-E533.
36. Matsubara M, Namioka K, Katayose S: Decreased plasma adiponectin concentrations in women with low-grade C-reactive protein elevation. Eur J Endocrinol 2003, 148:657-662.
37. Ouchi N, Kihara S, Funahashi T, et al.: Reciprocal association of C-reactive protein with adiponectin in blood stream and adipose tissue. Circulation 2003, 107:671-674.
38. Hattori Y, Matsumura M, Kasai K: Vascular smooth muscle cell activation by C-reactive protein. Cardiovasc Res 2003, 58:186-195.
39. Devaraj S, Xu DY, Jialal I: C-reactive protein increases plasminogen activator inhibitor-1 expression and activity in human aortic endothelial cells. Circulation 2003, 107:398-404.
40. Lindsay RS, Funahashi T, Hanson RL, et al.: Adiponectin and development of type 2 diabetes in the Pima Indian population. Lancet 2002, 360:57-58.
41. Spranger J, Kroke A, Mohlig M, et al.: Adiponectin and protection against type 2 diabetes mellitus. Lancet 2003, 361:226-228.
42. Esposito K, Pontillo A, Di Palo C, et al.: Effect of weight loss and lifestyle changes on vascular inflammatory markers in obese women: a randomized trial. JAMA 2003, 289: 1799-1804.
43. Sciacqua A, Candigliota M, Ceravolo R, et al.: Weight loss in combination with physical activity improves endothelial dysfunction in human obesity. Diabetes Care 2003, 26: 1673-1678.
44. Yatagai T, Nishida Y, Nagasaka S, et al.: Relationship between exercise training-induced increase in insulin sensitivity and adiponectinemia in healthy men. Endocr J 2003, 50:233-238.
45. Venugopal SK, Devaraj S, Yuhanna I, et al.: Demonstration that C-reactive protein decreases eNOS expression and bioactivity in human aortic endothelial cells. Circulation 2002, 106:1439-1441.
46. Fernandez-Real JM, Vayreda M, Richart C, et al.: Circulating interleukins 6 levels, blood pressure, and insulin sensitivity in apparently healthy men and women. J Clin Endocrinol Metab 2001, 86:1154-1159.
47. Chae CU, Lee RT, Rifai N, Ridker PM: Blood pressure and inflammation in apparently healthy men. Hypertension 2001, 38:399-403.
48. Abramson JL, Weintraub WS, Vaccarino V: Association between pulse pressure and C-reactive protein among apparently healthy US adults. Hypertension 2002, 39:197-202.
49. Bermudez EA, Rifai N, Buring J, et al.: Interrelationships among circulating interleukins-6, C-reactive protein, and traditional cardiovascular risk factors in women. Arterioscler Thromb Vasc Biol 2002, 22:1668-1673.
50. Seshiah PN, Weber DS, Rocic P, et al.: Angiotensin II stimulation of NAD(P)H oxidase activity. Circulation Res 2002, 91:406-413.
51. Furuhashi M, Ura N, Higashiura K, et al.: Blockade of the rennin-angiotensin system increases adiponectin concentrations in patients with essential hypertension. Hypertension 2003, 42: 76-81.
52. Das UN: Long-chain polyunsaturated fatty acids interact with nitric oxide, superoxide anion, and transforming growth factor-b to prevent human essential hypertension. Eur J Clin Nutr, In press.
53. Diamond J: The double puzzle of diabetes. Nature 2003, 423:599-602.
54. Jovinge S, Hamsten A, Tomvall P, et al.: Evidence for a role of tumor necrosis factor alpha in disturbances of triglycerides and glucose metabolism predisposing to coronary heart disease. Metabolism 1998, 47:113-118.
55. Corica F, Allegra A, Corsonello A, et al.: Relationship between plasma leptin levels and the tumor necrosis factor alpha system in obese subjects. Int J Obes Metab Disord 1999, 23:355-360.
56. Chu N-F, Spiegelman D, Rifai N, et al.: Glycemic status and soluble tumor necrosis factor receptor levels in relation to plasma leptin concentrations among normal weight and overweight US men. Int J Obes 2000, 24:1085-1092.
57. Denicola A, Batthyany C, Lissi E, et al.: Diffusion of nitric oxide into low density lipoprotein. J Biol Chem 2002, 277:932-936.
58. Das UN: Nutritional factors in the pathobiology of human essential hypertension. Nutrition 2001, 17:337-346.
59. Tomilinson JW, Moore J, Cooper MS, et al.: Regulation of expression of 11b-hydroxysteroid dehydrogenase type 1 in adipose tissue: tissue-specific induction by cytokines. Endocrinology 2001, 142:1982-1989.
60. Das UN: Is insulin an anti-inflammatory molecule? Nutrition 2001, 17:409-413.
61. Das UN: A Perinatal Strategy for Preventing Adult Disease: The Role of Long-Chain Polyunsaturated Fatty Acids. Boston: Kluwer Academic Publishers; 2002.
62. Jeschke MG, Einspanier R, Klein D, et al.: Insulin attenuates the systemic inflammatory response. Mol Med 2002, 8:443-450.
63. Gao F, Gao E, Yue T-L, et al.: Nitric oxide mediates the anti-apoptotic effect of insulin in myocardial ischemia-reperfusion. The roles of PI3-kinase, Akt, and endothelial nitric oxide synthase phosphorylation. Circulation 2002, 105:1497-1502.
64. Dandona P, Aljada A, Mohanty P: The anti-inflammatory and potential anti-atherogenic effect of insulin: a new paradigm. Diabetologia 2002, 45:924-930.
65. Whincup PH, Gilg JA, Papacosta O, et al.: Early evidence of ethnic differences in cardiovascular risk: cross sectional comparison of British South Asian and white children. BMJ 2002, 324:1-6.
66. Kalhan R, Puthawala K, Agarwal S, et al.: Altered lipid profile, leptin, insulin, and anthropometry in offspring of South Asian immigrants in the United States. Metabolism 2001, 50: 1197-1202.
67. Das UN: Pathobiology of metabolic syndrome X in obese and non-obese South Asian Indians: further discussion and some suggestions. Nutrition 2003, 19:560-562.
68. Berenson GS, Srinivasan SR: Prevention of atherosclerosis in childhood. Lancet 1999, 354:1223-1224.
69. Barker DJP: Mothers, Babies and Health in Later Life, edn 2. Edinburgh: Churchill Livingstone; 1998.
70. Barker DJ, Hales CN, Fall CH, et al.: Type 2 (non-insulin dependent) diabetes mellitus, hypertension, and hyperlipidemia (syndrome X): relation to reduced fetal growth. Diabetologia 1993, 36:62-67.
71. Lucas A, Fewtrell MS, Cole TJ: Fetal origins of adult disease-the hypothesis revisited. BMJ 1999, 319: 245-249.
72. Mokdad AH, Bowman BA, Ford ES, et al.: The continuing epidemics of obesity and diabetes in the United States. JAMA 2001, 286:1195-1200.
73. Krishnaswamy K, Prasad MPR: The changing epidemiologic scene: malnutrition versus chronic diseases in India. Nutrition 2001, 17:166-168.
74. Dandona P, Mohanty P, Ghanim H, et al.: The suppressive effect of dietary restriction and weight loss in the obese on the generation of reactive oxygen species by leukocytes, lipid peroxidation, and protein carboxylation. J Clin Endocrinol Metab 2001, 86:355-362.